JP Morgan Private Wealth Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-17,243
Closed -$672K 1943
2021
Q2
$672K Buy
+17,243
New +$618K ﹤0.01% 1372
2020
Q1
Sell
-6,649
Closed -$250K 1434
2019
Q4
$250K Sell
6,649
-3,040
-31% -$137K ﹤0.01% 1315
2019
Q3
$452K Buy
9,689
+3,087
+47% +$144K ﹤0.01% 1038
2019
Q2
$345K Sell
6,602
-11,616
-64% -$681K ﹤0.01% 1093
2019
Q1
$1.26M Buy
18,218
+695
+4% +$46.6K 0.01% 724
2018
Q4
$1.05M Sell
17,523
-3,688
-17% -$318K 0.01% 742
2018
Q3
$2.46M Buy
21,211
+1,788
+9% +$202K 0.01% 581
2018
Q2
$2.45M Buy
19,423
+663
+4% +$80.7K 0.01% 557
2018
Q1
$2.03M Buy
18,760
+2,959
+19% +$327K 0.01% 481
2017
Q4
$1.73M Sell
15,801
-1,184
-7% -$118K 0.01% 519
2017
Q3
$1.68M Buy
16,985
+2,307
+16% +$224K 0.01% 506
2017
Q2
$1.49M Buy
14,678
+1,037
+8% +$112K 0.01% 522
2017
Q1
$1.58M Buy
13,641
+1,296
+10% +$151K 0.01% 523
2016
Q4
$1.48M Sell
12,345
-1,787
-13% -$198K 0.01% 497
2016
Q3
$1.59M Sell
14,132
-559
-4% -$64.4K 0.01% 487
2016
Q2
$1.82M Sell
14,691
-3,083
-17% -$372K 0.02% 460
2016
Q1
$2M Buy
17,774
+3,750
+27% +$390K 0.02% 401
2015
Q4
$1.52M Buy
14,024
+235
+2% +$26.9K 0.02% 430
2015
Q3
$1.38M Sell
13,789
-1,714
-11% -$186K 0.02% 401
2015
Q2
$1.77M Sell
15,503
-26
-0.2% -$3.15K 0.02% 394
2015
Q1
$1.62M Sell
15,529
-629
-4% -$67K 0.02% 417
2014
Q4
$1.95M Sell
16,158
-62,549
-79% -$8.22M 0.02% 381
2014
Q3
$11.5M Buy
78,707
+24,261
+45% +$3.74M 0.15% 153
2014
Q2
$9.1M Buy
54,446
+43,884
+415% +$7.81M 0.15% 146
2014
Q1
$2.1M Buy
10,562
+8,149
+338% +$1.54M 0.04% 277
2013
Q4
$461K Buy
+2,413
New +$449K 0.01% 464

Other funds holding CLB

JP Morgan Private Wealth Advisors's CLB Position: Q3 2021 in Review

JP Morgan Private Wealth Advisors sold out of Core Laboratories (CLB) in Q3 2021, closing a stake of 17,243 shares — an estimated $672K sold.

JP Morgan Private Wealth Advisors first reported a position in CLB in Q4 2013 and held it in 26 quarters. The position peaked at $11.5M in Q3 2014. 198 funds tracked by Wall St. Rank hold CLB as of Q3 2021.

  • JP Morgan Private Wealth Advisors reported no remaining Core Laboratories position as of Q3 2021 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 17,243 Core Laboratories shares in Q3 2021, an estimated $672K.
  • JP Morgan Private Wealth Advisors first reported a position in Core Laboratories in Q4 2013 and held it in 26 quarters.
  • JP Morgan Private Wealth Advisors's Core Laboratories position peaked at $11.5M in Q3 2014.
  • 198 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2021.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.